Daisuke Takahari
0000-0002-2492-6014
115 papers found
Refreshing results…
Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy
Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
Second-line chemotherapy with irinotecan plus cisplatin after the failure of S-1 monotherapy for advanced gastric cancer
Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer
Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel
Folate Intake along with Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Thymidylate Synthase in Patients with Advanced Gastric Cancer
Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Pre-treated Metastatic Colorectal Cancer Harboring Wild-type KRAS
Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS
Effects of Genetic Polymorphisms in the ABCB1 Gene on Clinical Outcomes in Patients with Gastric Cancer Treated by Second-line Chemotherapy
Improvement of Oral Intake following Chemotherapy in Gastric Cancer Patients with an Inability to Eat
Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: A retrospective study
Case Series of Cetuximab Monotherapy for Patients with Pre-treated Colorectal Cancer Complicated with Hyperbilirubinemia due to Severe Liver Metastasis
Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis
Vascular Endothelial Growth Factor Receptor Expression as a Prognostic Marker for Survival in Colorectal Cancer
Neutropaenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX
Impact of vascular endothelial growth factor receptor 1, 2, and 3 expression on the outcome of patients with gastric cancer
Chemoradiotherapy for esophageal cancer
A case of nonresectable esophageal cancer undergoing induction chemotherapy using the DCF regimen followed by curative surgery
Chemotherapy for Patients With Advanced Gastric Cancer With Performance Status 2
Relationships of Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor Expression to Clinical Outcomes in Patients with Colorectal Cancer
Missing publications? Search for publications with a matching author name.